After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Dr. Reddy’s Laboratories Ltd. ADR is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Dr. Reddy’s Laboratories Ltd. ADR is $10.36B. A total of 2.67 million shares were traded on the day, compared to an average of 2.04M shares.
In the most recent transaction, Israeli Erez bought 65,500 shares of RDY for 82.29 per share on Jul 29 ’24.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Dr. Reddy’s Laboratories Ltd. ADR pays an annual dividend of $0.48, resulting in a dividend yield of 3.83%, and it has a price to earnings (P/E) ratio of 16.16. RDY’s most recent ex-dividend date was 0.5% when it declared a $0.0814 quarterly dividend that was paid in cash on 7/15/2024. Previously, the company paid the dividend on 1/1/2100 with an ex-dividend date of 0.7%. The RDY stock dividend was $0.0975 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RDY has a high of $16.89 and a low of $12.28.
As of this writing, RDY has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RDY’s latest balance sheet shows that the firm has $44.37B in Cash & Short Term Investments as of fiscal 2022. There were $33.84B in debt and $94.02B in liabilities at the time. Its Book Value Per Share was $4.45, while its Total Shareholder’s Equity was $190.53B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RDY is Buy with a score of 3.25.
